Renee Leck | Director-Investor Relations |
Bobby Gaspar | Chief Executive Officer |
Frank Thomas | Chief Operating Officer |
Whitney Ijem | Guggenheim |
Esther Rajavelu | Oppenheimer |
Yaron Werber | Cowen |
Peter Kim | Barclays |
Ladies and gentlemen, thank you for standing by, and welcome to the Orchard Therapeutics First Quarter 2020 Investor Conference Call. [Operator Instructions] I would now like to hand off the conference over to your speaker today, Renee Leck, Director of Investor Relations. Please go ahead, ma’am.
Thanks, Sonia. Good morning, everyone, and welcome to Orchard’s first quarter 2020 investor call.